1. Urticaria Voices: Patients' perspective on the negative impact of chronic spontaneous urticaria on their lives as well as their treatment goals.
- Author
-
Coste, M., Weller, K., Laires, P., Balp, M.M., Raftery, T., Saraswat, P., Mccarthy, J., Dricu, M., Winders, T.A., and Bernstein, J.A.
- Abstract
Chronic spontaneous urticaria (CSU) can significantly impact health-related quality of life (HRQoL). This study investigated the burden of CSU on HRQoL and patients' personal treatment goals. Urticaria Voices is a global cross-sectional online survey with CSU patients (self-reported clinician-provided diagnosis of CSU, recruited through nationally representative online panels of the general population and patient advocacy groups) in the US, Canada, UK, Germany, France, Italy, Japan. The perceived negative impact of CSU on 6 HRQoL domains (mental & emotional wellbeing, social life & intimate relationships, activities of daily living, family life, professional & academic life, finances) and the personal importance of 16 treatment goals were assessed with a 10-point Likert scale. Symptoms control was assessed with the UCT. Statistical differences in HRQoL between adequately and inadequately controlled patients were assessed with independent sample t -tests assuming unequal variances. In all, 582 CSU patients responded to the survey. Most patients (80%) were inadequately controlled (UCT < 12) and reported a significantly (P < 0.001) higher negative impact than controlled patients on the 6 HRQoL domains assessed, with the most impacted domains being mental & emotional wellbeing, social life & intimate relationships, and activities of daily living. Among inadequately controlled patients, 82% reported currently taking antihistamine (AH) for their CSU after their doctor had already on average switched the types of AH 2.4 times and increased dosage 2 times. Regarding treatment goals, patients rated as extremely important being free of itch and hives, having complete control over symptoms, improved quality of life and staying in remission over the long-term. In all, 4/5 of the CSU patients in this study were inadequately controlled on their current treatment, with 82% of them being on AH. These patients reported a significantly higher negative impact across all HRQoL domains compared to adequately controlled patients. Treatments that target symptom relief, complete control and improved HRQoL are important for CSU patients and therapies, which address these goals effectively, are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF